Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine | decreases expression | EXP | | 6480464 | chlorcyclizine results in decreased expression of BOD1L1 mRNA | CTD | PMID:21058326 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of BOD1L1 mRNA | CTD | PMID:32145629 | 2,2',5,5'-tetrachlorobiphenyl | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:23829299 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of BOD1L1 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BOD1L1 mRNA | CTD | PMID:33387578 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Bod1l (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of BOD1L mRNA | CTD | PMID:26251327 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | BOD1L1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BOD1L1 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | BOD1L1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BOD1L1 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | decreases expression | ISO | Bod1l (Mus musculus) | 6480464 | bisphenol S results in decreased expression of BOD1L mRNA | CTD | PMID:33297965 | arsenite(3-) | multiple interactions | ISO | BOD1L1 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to BOD1L1 mRNA] | CTD | PMID:32406909 | arsenous acid | increases expression | ISO | BOD1L1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of BOD1L1 mRNA | CTD | PMID:26705709 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of BOD1L1 mRNA | CTD | PMID:25181051 and PMID:32145629 | bisphenol A | decreases expression | ISO | Bod1l (Mus musculus) | 6480464 | bisphenol A results in decreased expression of BOD1L mRNA | CTD | PMID:33221593 and PMID:38074096 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with tributyltin] results in increased expression of BOD1L1 mRNA | CTD | PMID:31129395 | cadmium dichloride | decreases expression | ISO | Bod1l (Mus musculus) | 6480464 | Cadmium Chloride results in decreased expression of BOD1L mRNA | CTD | PMID:24982889 | caffeine | affects phosphorylation | ISO | BOD1L1 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of BOD1L1 protein | CTD | PMID:35688186 | carbonyl sulfide | increases expression | EXP | | 6480464 | carbonyl sulfide results in increased expression of BOD1L1 mRNA | CTD | PMID:19395590 | CGP 52608 | multiple interactions | ISO | BOD1L1 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to BOD1L1 gene] | CTD | PMID:28238834 | cisplatin | increases phosphorylation | ISO | Bod1l (Mus musculus) | 6480464 | Cisplatin results in increased phosphorylation of BOD1L protein | CTD | PMID:22006019 | cisplatin | decreases expression | ISO | BOD1L1 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of BOD1L1 mRNA | CTD | PMID:27594783 | clorgyline | increases expression | ISO | BOD1L1 (Homo sapiens) | 6480464 | Clorgyline results in increased expression of BOD1L1 mRNA | CTD | PMID:19691856 | copper(II) sulfate | increases expression | ISO | BOD1L1 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of BOD1L1 mRNA | CTD | PMID:19549813 | coumarin | affects phosphorylation | ISO | BOD1L1 (Homo sapiens) | 6480464 | coumarin affects the phosphorylation of BOD1L1 protein | CTD | PMID:35688186 | DDT | decreases expression | EXP | | 6480464 | DDT results in decreased expression of BOD1L1 mRNA | CTD | PMID:30207508 | decabromodiphenyl ether | decreases expression | EXP | | 6480464 | decabromobiphenyl ether results in decreased expression of BOD1L1 mRNA | CTD | PMID:23914054 | dexamethasone | multiple interactions | ISO | BOD1L1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BOD1L1 mRNA | CTD | PMID:28628672 | diarsenic trioxide | increases expression | ISO | BOD1L1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of BOD1L1 mRNA | CTD | PMID:26705709 | dioxygen | increases expression | ISO | Bod1l (Mus musculus) | 6480464 | Oxygen deficiency results in increased expression of BOD1L mRNA | CTD | PMID:24205000 | enzyme inhibitor | multiple interactions | ISO | BOD1L1 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of BOD1L protein | CTD | PMID:23301498 | ethanol | affects splicing | ISO | Bod1l (Mus musculus) | 6480464 | Ethanol affects the splicing of BOD1L mRNA | CTD | PMID:30319688 | ethyl methanesulfonate | increases expression | ISO | BOD1L1 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of BOD1L mRNA | CTD | PMID:23649840 | FR900359 | affects phosphorylation | ISO | BOD1L1 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of BOD1L1 protein | CTD | PMID:37730182 | geldanamycin | increases expression | ISO | BOD1L1 (Homo sapiens) | 6480464 | geldanamycin results in increased expression of BOD1L1 mRNA | CTD | PMID:26705709 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of BOD1L1 mRNA | CTD | PMID:33387578 | hexadecanoic acid | decreases phosphorylation | ISO | BOD1L1 (Homo sapiens) | 6480464 | Palmitic Acid results in decreased phosphorylation of BOD1L1 protein | CTD | PMID:28073184 | hydrogen peroxide | multiple interactions | ISO | Bod1l (Mus musculus) | 6480464 | [Hydrogen Peroxide co-treated with N-(oxo-5 more ... | CTD | PMID:31494107 | indometacin | multiple interactions | ISO | BOD1L1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BOD1L1 mRNA | CTD | PMID:28628672 | irinotecan | decreases expression | ISO | BOD1L1 (Homo sapiens) | 6480464 | Irinotecan analog results in decreased expression of BOD1L1 mRNA | CTD | PMID:18927307 | methyl methanesulfonate | increases expression | ISO | BOD1L1 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of BOD1L mRNA | CTD | PMID:23649840 | methylparaben | increases expression | ISO | BOD1L1 (Homo sapiens) | 6480464 | methylparaben results in increased expression of BOD1L1 mRNA | CTD | PMID:31745603 | perfluorooctane-1-sulfonic acid | decreases expression | ISO | BOD1L1 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of BOD1L1 mRNA | CTD | PMID:27153767 | phenethyl isothiocyanate | decreases expression | EXP | | 6480464 | phenethyl isothiocyanate results in decreased expression of BOD1L1 mRNA | CTD | PMID:17616710 | phenobarbital | decreases expression | ISO | Bod1l (Mus musculus) | 6480464 | Phenobarbital results in decreased expression of BOD1L mRNA | CTD | PMID:23091169 | resveratrol | multiple interactions | ISO | BOD1L1 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of BOD1L mRNA | CTD | PMID:23557933 | senecionine | decreases expression | ISO | Bod1l (Mus musculus) | 6480464 | senecionine results in decreased expression of BOD1L protein | CTD | PMID:35357534 | sodium fluoride | decreases expression | ISO | Bod1l (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of BOD1L mRNA | CTD | PMID:27862939 | thimerosal | decreases expression | ISO | BOD1L1 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of BOD1L1 mRNA | CTD | PMID:27188386 | toluene | increases expression | ISO | BOD1L1 (Homo sapiens) | 6480464 | Toluene results in increased expression of BOD1L1 mRNA | CTD | PMID:28245982 | torcetrapib | increases expression | ISO | BOD1L1 (Homo sapiens) | 6480464 | torcetrapib results in increased expression of BOD1L mRNA | CTD | PMID:23228038 | tributylstannane | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with tributyltin] results in increased expression of BOD1L1 mRNA | CTD | PMID:31129395 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of BOD1L1 mRNA | CTD | PMID:33387578 | troglitazone | decreases expression | ISO | Bod1l (Mus musculus) | 6480464 | troglitazone results in decreased expression of BOD1L1 mRNA | CTD | PMID:28973697 | valproic acid | decreases expression | ISO | BOD1L1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of BOD1L mRNA | CTD | PMID:23179753 | valproic acid | increases expression | ISO | BOD1L1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of BOD1L1 mRNA | CTD | PMID:26705709 | vorinostat | decreases expression | ISO | BOD1L1 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of BOD1L1 mRNA | CTD | PMID:27188386 | |